US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CAR-T Concept

1,493.01

-5.6439-0.38%

Number of Gainers:1

Number of Losers:1

Number of Flat:- -

PE:- -

High:1,514.82

Open:1,502.97

Low:1,491.11

Close:1,498.65

Volume:6.84M

Turnover:804.74M

Market Cap:388.22B

Float Cap:376.24B

Loading ...

Gilead Sciences’ Promising Phase 3 Study in Lung Cancer Treatment

Gilead Sciences Advances HIV-1 Treatment with New Clinical Study on GS-3242

Gilead Sciences Advances Ulcerative Colitis Treatment with New Filgotinib Study

Gilead Sciences Advances in NSCLC Treatment: Key Study Update

Suze Orman reveals her favorite stock right now and the investing mistake that shaped her strategy

Gilead Sciences Advances Lung Cancer Treatment with New Clinical Study

Swiss Pharma Stocks Price in Potential Hit From Trump Policies -- Market Talk

Gilead Sciences (GILD) Receives a Buy from BMO Capital

Gilead Sciences Stock (GILD) Turns Negative As CVS Says No To HIV Prevention Drug

Gilead Sciences Advances Ulcerative Colitis Treatment with Filgotinib Study

Why Gilead Sciences (GILD) Shares Are Sliding Today

stock_story_highlight

Gilead's Kite to Acquire Interius BioTherapeutics for $350 Million to Boost In Vivo CAR Therapeutics

Kite: Transaction With Interius Is Expected to Reduce Gilead's Gaap and Non-Gaap 2025 EPS by Approximately $0.23-$0.25

THOMSON REUTERS

Kite to Acquire Interius Biotherapeutics to Advance in Vivo Platform

THOMSON REUTERS

Kite: Proposed Deal for $350 Mln.

THOMSON REUTERS

Shares of Gilead Down 2.9% Premarket After Reuters Report CVS Holds off Adding Co's New Hiv Prevention Shot to Drug Coverage Lists

THOMSON REUTERS

Gilead Sciences Inc. to Present at Cantor Global Healthcare Conference

Gilead price target raised to $135 from $120 at Bernstein

Walgreens Specialty Pharmacy Expands Limited Distribution Network

MT Newswires Live

Gilead upgraded to Outperform from Neutral at Daiwa

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4578/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T Concept","latestPrice":1493.0099,"timestamp":1755892799999,"preClose":1498.6538,"halted":0,"volume":6842396,"delay":0,"changeRate":-0.003766,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-5.643921,"latestTime":"08-22 16:00:00 EDT","open":1502.9719,"high":1514.8237,"low":1491.1144,"amount":804735334.080462,"amplitude":0.01582,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1756108800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.300111,"peRate":19.456977,"turnoverRate":0.00222,"increases":1,"decrements":1,"flats":0,"marketCap":388222042112,"floatMarketCap":376240160768},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1514.8237,"amplitude":0.01582,"preClose":1498.6538,"low":1491.1144,"pbRate":"6.300111","latestPrice":1493.0099,"volume":6842396,"delay":0,"open":1502.9719,"prevYearClose":1164.883,"prevWeekClose":1489.4918,"prevMonthClose":1382.28,"prevQuarterClose":1430.2296,"fiveDayClose":1489.4918,"twentyDayClose":1430.4186,"sixtyDayClose":1350.1843,"secType":"PLATE","market":"US","turnoverRate":0.00222,"peRate":19.456977,"marketCap":388222042112,"floatMarketCap":376240160768,"timestamp":1755892799999,"nameCN":"CAR-T Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":1,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2562269548","title":"Gilead Sciences’ Promising Phase 3 Study in Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2562269548","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562269548?lang=en_us&edition=fundamental","pubTime":"2025-08-25 00:37","pubTimestamp":1756053465,"startTime":"0","endTime":"0","summary":"Gilead Sciences (($GILD)) announced an update on their ongoing clinical study. Gilead Sciences is currently conducting a Phase 3 clinical study tit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gilead-sciences-promising-phase-3-study-in-lung-cancer-treatment-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gilead-sciences-promising-phase-3-study-in-lung-cancer-treatment-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089984988.USD","LU2324357040.USD","LU0289739699.SGD","SG9999015978.USD","IE00BKVL7J92.USD","BK4532","BK4139","LU0109394709.USD","BK4583","LU1674673691.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU1430594728.SGD","IE0002270589.USD","LU1571399168.USD","LU0320765992.SGD","SG9999015945.SGD","IE00B7SZLL34.SGD","LU1674673428.USD","BK4588","IE00B3T34201.USD","SG9999015952.SGD","LU1585245621.USD","IE00BZ1G4Q59.USD","BK4566","LU0234570918.USD","LU1778281490.HKD","LU0058720904.USD","LU0889565916.HKD","BK4568","BK4550","SG9999015986.USD","LU1066053197.SGD","LU2087621335.USD","IE00B19Z3581.USD","GILD","LU1839511570.USD","LU1066051498.USD","LU2468319806.SGD","BK4585","BK4578","LU0823416689.USD"],"gpt_icon":0},{"id":"2562026937","title":"Gilead Sciences Advances HIV-1 Treatment with New Clinical Study on GS-3242","url":"https://stock-news.laohu8.com/highlight/detail?id=2562026937","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562026937?lang=en_us&edition=fundamental","pubTime":"2025-08-25 00:35","pubTimestamp":1756053323,"startTime":"0","endTime":"0","summary":"Gilead Sciences (($GILD)) announced an update on their ongoing clinical study. Gilead Sciences is currently recruiting participants for a clinical ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gilead-sciences-advances-hiv-1-treatment-with-new-clinical-study-on-gs-3242?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gilead-sciences-advances-hiv-1-treatment-with-new-clinical-study-on-gs-3242?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1868836914.USD","BK4504","GILD","LU0289739699.SGD","LU2471134796.USD","LU1791807156.HKD","LU1839511570.USD","LU0742534661.SGD","BK4585","SG9999015986.USD","IE0004086264.USD","LU2237443549.SGD","BK4139","BK4552","LU1778281490.HKD","IE00B19Z3B42.SGD","LU1868836591.USD","LU0251142724.SGD","LU0251131958.USD","BK4532","LU1066053197.SGD","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","BK4578","LU1668664300.SGD","LU2089984988.USD","LU0061475181.USD","LU1868837136.USD","IE0034235188.USD","LU2237443382.USD","LU1585245621.USD","LU2468319806.SGD","SG9999015945.SGD","SG9999015952.SGD","IE00BZ1G4Q59.USD","LU1430594728.SGD","LU2471134879.HKD","BK4533","BK4516","LU1868837300.USD","BK4583","SG9999015978.USD","LU0058720904.USD","IE00BFXG1179.USD","BK4568","LU1894683348.USD","IE0002270589.USD","LU2237443895.HKD","LU2471134523.USD","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2562377269","title":"Gilead Sciences Advances Ulcerative Colitis Treatment with New Filgotinib Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2562377269","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562377269?lang=en_us&edition=fundamental","pubTime":"2025-08-25 00:35","pubTimestamp":1756053317,"startTime":"0","endTime":"0","summary":"Gilead Sciences (($GILD)) announced an update on their ongoing clinical study. Gilead Sciences, in collaboration with Eisai Korea Inc., is conducti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gilead-sciences-advances-ulcerative-colitis-treatment-with-new-filgotinib-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gilead-sciences-advances-ulcerative-colitis-treatment-with-new-filgotinib-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU1430594728.SGD","IE00B19Z3B42.SGD","LU1674673691.USD","BK4532","LU0109394709.USD","LU1674673428.USD","LU0234570918.USD","LU0320765992.SGD","BK4550","LU0058720904.USD","LU2089984988.USD","LU1571399168.USD","LU0823416689.USD","BK4139","IE00B7SZLL34.SGD","IE0002270589.USD","GILD","LU2468319806.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","SG9999015952.SGD","SG9999015986.USD","LU1066051498.USD","IE00B19Z3581.USD","LU1778281490.HKD","BK4566","LU1585245621.USD","BK4568","LU2087621335.USD","IE00B3T34201.USD","BK4578","SG9999015945.SGD","LU2324357040.USD","LU1066053197.SGD","LU1839511570.USD","LU0889565916.HKD","LU0289739699.SGD","BK4588","SG9999015978.USD","IE00BSNM7G36.USD","BK4583"],"gpt_icon":0},{"id":"2562269595","title":"Gilead Sciences Advances in NSCLC Treatment: Key Study Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2562269595","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562269595?lang=en_us&edition=fundamental","pubTime":"2025-08-25 00:33","pubTimestamp":1756053193,"startTime":"0","endTime":"0","summary":"Gilead Sciences (($GILD)) announced an update on their ongoing clinical study. Gilead Sciences, in collaboration with Merck Sharp & Dohme LLC, is c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gilead-sciences-advances-in-nsclc-treatment-key-study-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gilead-sciences-advances-in-nsclc-treatment-key-study-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","GILD","LU0289739699.SGD","LU1839511570.USD","LU0109394709.USD","BK4585","BK4588","LU2324357040.USD","SG9999015986.USD","IE00BSNM7G36.USD","BK4139","LU0889565916.HKD","LU1778281490.HKD","IE00B19Z3B42.SGD","LU1571399168.USD","BK4532","LU1066053197.SGD","IE00B19Z3581.USD","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","BK4578","LU2089984988.USD","BK4550","LU2468319806.SGD","SG9999015945.SGD","LU1585245621.USD","SG9999015952.SGD","IE00BZ1G4Q59.USD","LU1430594728.SGD","LU1674673428.USD","SG9999015978.USD","BK4583","LU0058720904.USD","BK4566","LU0234570918.USD","BK4568","LU1674673691.USD","IE0002270589.USD","LU0320765992.SGD","LU1066051498.USD","LU2087621335.USD","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2561237292","title":"Suze Orman reveals her favorite stock right now and the investing mistake that shaped her strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2561237292","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561237292?lang=en_us&edition=fundamental","pubTime":"2025-08-24 02:09","pubTimestamp":1755972540,"startTime":"0","endTime":"0","summary":"The personal-finance guru talks tech stocks, crypto and her targets for the S&P 500 and bitcoin. Suze Orman: \"Always trust yourself more than you trust others.\". Suze Orman is a two-time Emmy Award-winning television host and the author of 10 consecutive New York Times bestsellers on personal finance. She has been named twice to Time magazine's list of the 100 most influential people and is widely recognized for her work in financial education.Orman currently hosts the \"Women & Money\" podcast, where she discusses personal-finance topics, and is the co-founder of SecureSave, a company focused on workplace emergency-savings programs. Orman's career spans television, publishing and entrepreneurship, with an emphasis on helping individuals manage money and plan for financial security.In this recent interview, edited for length and clarity, Orman shares her top stock picks, her short-term outlook for the U.S. stock market, her take on cryptocurrencies - and the biggest investment mistake sh","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","MBTmain","BTC.USD.HKCC","XBI","BK4578","VOO","LU1989772923.USD","BK4220","UPRO","SMH","LU0889566641.SGD","META","GEV","MESmain","SHOP","ESmain","BTC.USD.CC","FOMO","SDS","SPY","IVV","FDN","CTRE","OEX","MSFT","SPXU","LU1046421795.USD","AVGO","OEF","GILD","BLK","USAW.SI","STRK","LU2265009873.SGD","SH","MACW.SI","PLTR",".SPX","LU1868837136.USD","SSO"],"gpt_icon":1},{"id":"2561409678","title":"Gilead Sciences Advances Lung Cancer Treatment with New Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2561409678","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561409678?lang=en_us&edition=fundamental","pubTime":"2025-08-23 00:15","pubTimestamp":1755879343,"startTime":"0","endTime":"0","summary":"Gilead Sciences (($GILD)), Gilead Sciences (($CC:GILD.CUR)) announced an update on their ongoing clinical study. Gilead Sciences, in collaboration ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gilead-sciences-advances-lung-cancer-treatment-with-new-clinical-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gilead-sciences-advances-lung-cancer-treatment-with-new-clinical-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2087621335.USD","LU0889565916.HKD","IE0002270589.USD","LU0109394709.USD","LU0234570918.USD","LU1066051498.USD","LU0058720904.USD","IE00B19Z3581.USD","LU0289739699.SGD","SG9999015978.USD","BK4550","LU1674673691.USD","LU1585245621.USD","BK4532","LU1571399168.USD","LU1778281490.HKD","LU1839511570.USD","IE00BKVL7J92.USD","LU0823416689.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","BK4566","SG9999015952.SGD","IE00B19Z3B42.SGD","IE00B3T34201.USD","IE00BSNM7G36.USD","LU2324357040.USD","IE00B7SZLL34.SGD","LU1066053197.SGD","SG9999015945.SGD","BK4588","BK4578","GILD","LU0320765992.SGD","LU1674673428.USD","SG9999015986.USD","BK4568","LU2468319806.SGD","BK4139","BK4583","LU1430594728.SGD","BK4585"],"gpt_icon":0},{"id":"2561756406","title":"Swiss Pharma Stocks Price in Potential Hit From Trump Policies -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2561756406","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561756406?lang=en_us&edition=fundamental","pubTime":"2025-08-23 00:03","pubTimestamp":1755878580,"startTime":"0","endTime":"0","summary":"1603 GMT - The results of a U.S. probe into the pharmaceutical sector are imminent, but any potential hits from President Trump's tariffs and drug-price policies seem to be already priced in by Swiss pharma stocks, Vontobel's Stefan Schneider says in a note. Vontobel estimates U.S. drug prices could be cut by between 5% and 33%, but finds that this is already factored into Swiss pharma stock prices. According to Vontobel's analysis, Roche shares could see a movement from 0% in its base-case scenario to a 7% drop in its worst-case scenario, while Novartis shares could either rise or fall by 8%. This means the outcome of the U.S. investigation could also trigger share-price rises as a clearer picture emerges, the analyst says. Shares in Novartis and Roche close 0.9% and 0.4% lower, respectively. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","LU0320765489.SGD","NVS","LU0208291251.USD","03165","IE0009355771.USD","RHHBY","IE00BJT1NW94.SGD","IE0002141913.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4588","IE00B4R5TH58.HKD","BK4007","LU0070302665.USD","IE00BJJMRZ35.SGD","BK4585","LU0211331839.USD","BK4532"],"gpt_icon":0},{"id":"2561549788","title":"Gilead Sciences (GILD) Receives a Buy from BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2561549788","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561549788?lang=en_us&edition=fundamental","pubTime":"2025-08-22 00:35","pubTimestamp":1755794121,"startTime":"0","endTime":"0","summary":"In a report released today, Evan Seigerman from BMO Capital reiterated a Buy rating on Gilead Sciences, with a price target of $130.00. The company...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-bmo-capital-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-bmo-capital-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BZ1G4Q59.USD","BK4566","LU1674673428.USD","BK4550","IE00B19Z3B42.SGD","LU2089984988.USD","IE0002270589.USD","LU1585245621.USD","LU1066051498.USD","LU0320765992.SGD","LU1430594728.SGD","SG9999015945.SGD","LU2087621335.USD","IE00B19Z3581.USD","SG9999015986.USD","BK4139","LU0889565916.HKD","IE00B7SZLL34.SGD","SG9999015952.SGD","BMO","LU1066053197.SGD","LU0234570918.USD","LU1778281490.HKD","BK4588","LU0823416689.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","BK4532","BK4578","LU1674673691.USD","LU2468319806.SGD","SG9999015978.USD","IE00B3T34201.USD","BK4207","LU0289739699.SGD","LU0109394709.USD","LU2324357040.USD","BK4585","BK4568","BK4583","LU1571399168.USD","LU0058720904.USD","GILD","LU1839511570.USD"],"gpt_icon":0},{"id":"2561492616","title":"Gilead Sciences Stock (GILD) Turns Negative As CVS Says No To HIV Prevention Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2561492616","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561492616?lang=en_us&edition=fundamental","pubTime":"2025-08-22 00:11","pubTimestamp":1755792696,"startTime":"0","endTime":"0","summary":"Shares in biopharmaceutical group Gilead Sciences ($GILD) dropped 1% today after pharmacy firm CVS Health ($CVS) gave the thumbs down to its new HI...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-turns-negative-as-cvs-says-no-to-hiv-prevention-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-turns-negative-as-cvs-says-no-to-hiv-prevention-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","LU0320765489.SGD","LU0109394709.USD","LU1571399168.USD","LU1839511570.USD","LU2087621335.USD","LU1585245621.USD","BK4581","LU0070302665.USD","LU2089984988.USD","IE00B7SZLL34.SGD","LU1066051498.USD","IE00BKVL7J92.USD","BK4566","LU0061475181.USD","LU1778281490.HKD","IE00BZ1G4Q59.USD","BK4504","BK4139","LU0234570918.USD","LU0006061336.USD","LU0823416689.USD","CVS","IE00B19Z3B42.SGD","IE0002270589.USD","LU1059921491.USD","SG9999015978.USD","IE00B3T34201.USD","LU1674673691.USD","LU1699723380.USD","BK4578","SG9999015986.USD","IE00BSNM7G36.USD","LU1674673428.USD","LU2468319806.SGD","LU0208291251.USD","GILD","LU0320765992.SGD","SG9999015952.SGD","BK4196","BK4585","LU0211331839.USD","IE00B19Z3581.USD","LU0058720904.USD","LU0289739699.SGD","LU0889565916.HKD","BK4532","LU1066053197.SGD","LU2324357040.USD","BK4588"],"gpt_icon":0},{"id":"2561921384","title":"Gilead Sciences Advances Ulcerative Colitis Treatment with Filgotinib Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2561921384","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561921384?lang=en_us&edition=fundamental","pubTime":"2025-08-22 00:05","pubTimestamp":1755792305,"startTime":"0","endTime":"0","summary":"Gilead Sciences (($GILD)), Gilead Sciences (($CC:GILD.CUR)) announced an update on their ongoing clinical study. Study Overview: Gilead Sciences, i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gilead-sciences-advances-ulcerative-colitis-treatment-with-filgotinib-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gilead-sciences-advances-ulcerative-colitis-treatment-with-filgotinib-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2468319806.SGD","BK4139","IE00BKVL7J92.USD","LU1066053197.SGD","IE00B7SZLL34.SGD","LU2089984988.USD","LU1674673691.USD","LU1571399168.USD","LU1066051498.USD","BK4566","LU0889565916.HKD","LU1674673428.USD","BK4588","IE0002270589.USD","LU0109394709.USD","LU2087621335.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","SG9999015945.SGD","BK4568","IE00B3T34201.USD","BK4585","SG9999015978.USD","IE00B19Z3581.USD","LU0234570918.USD","LU0320765992.SGD","SG9999015952.SGD","LU0058720904.USD","BK4583","LU2324357040.USD","BK4550","BK4532","LU0289739699.SGD","LU1778281490.HKD","LU1839511570.USD","LU1430594728.SGD","LU1585245621.USD","BK4578","LU0823416689.USD","SG9999015986.USD","GILD","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"2561497992","title":"Why Gilead Sciences (GILD) Shares Are Sliding Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2561497992","media":"stock_story_highlight","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561497992?lang=en_us&edition=fundamental","pubTime":"2025-08-21 23:16","pubTimestamp":1755789360,"startTime":"0","endTime":"0","summary":"Shares of biopharmaceutical company Gilead Sciences (NASDAQ:GILD)\r\n fell 3.5% in the morning session after reports that CVS Health will not be adding the company's new HIV prevention drug, Yeztugo, to its commercial insurance plans for now.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockstory.org/us/stocks/nasdaq/gild/news/why-up-down/why-gilead-sciences-gild-shares-are-sliding-today","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_story_highlight","symbols":["LU2324357040.USD","SG9999015986.USD","GILD","IE00B19Z3581.USD","LU0320765992.SGD","LU1674673428.USD","LU1674673691.USD","SG9999015945.SGD","BK4566","LU0823416689.USD","LU1430594728.SGD","LU0109394709.USD","IE0002270589.USD","LU0889565916.HKD","LU2087621335.USD","IE00BKVL7J92.USD","LU1839511570.USD","BK4139","LU0234570918.USD","LU0058720904.USD","IE00B19Z3B42.SGD","LU1585245621.USD","LU0289739699.SGD","SG9999015952.SGD","BK4585","BK4532","LU1066053197.SGD","LU1571399168.USD","LU1778281490.HKD","BK4550","IE00B7SZLL34.SGD","BK4583","IE00BZ1G4Q59.USD","BK4578","IE00BSNM7G36.USD","LU2468319806.SGD","BK4568","SG9999015978.USD","LU2089984988.USD","IE00B3T34201.USD","LU1066051498.USD","BK4588"],"gpt_icon":0},{"id":"2561122460","title":"Gilead's Kite to Acquire Interius BioTherapeutics for $350 Million to Boost In Vivo CAR Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2561122460","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561122460?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:31","pubTimestamp":1755779464,"startTime":"0","endTime":"0","summary":"Kite, a Gilead Company, has announced a definitive agreement to acquire Interius BioTherapeutics, a privately held biotechnology firm, for $350 million. Interius is known for its development of in vivo CAR therapeutics. The acquisition is set to enhance Kite's cell therapy capabilities by integrating Interius's in vivo platform, which allows the generation of CAR T-cells directly within a patient's body. This innovative approach could potentially streamline treatment processes by eliminating the need for cell harvesting and reinfusion associated with traditional therapies. Interius's team will join Kite's research operations, forming a center of excellence in Philadelphia to expedite the development of next-generation in vivo therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDL2x9ySD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU0058720904.USD","LU1778281490.HKD","SG9999015978.USD","SG9999015986.USD","BK4566","LU0289739699.SGD","LU0823416689.USD","LU1066053197.SGD","IE00B3T34201.USD","IE00B7SZLL34.SGD","LU2468319806.SGD","LU2087621335.USD","SG9999015945.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","SG9999015952.SGD","LU0889565916.HKD","BK4583","LU0109394709.USD","LU0320765992.SGD","LU1571399168.USD","LU1430594728.SGD","BK4585","GILD","LU0234570918.USD","LU1585245621.USD","LU1839511570.USD","IE00B19Z3581.USD","IE0002270589.USD","BK4578","IE00B19Z3B42.SGD","BK4568","LU1066051498.USD","BK4588","BK4532","LU1674673428.USD","LU2324357040.USD","LU1674673691.USD","IE00BSNM7G36.USD","BK4139","LU2089984988.USD"],"gpt_icon":0},{"id":"2561606104","title":"Kite: Transaction With Interius Is Expected to Reduce Gilead's Gaap and Non-Gaap 2025 EPS by Approximately $0.23-$0.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2561606104","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561606104?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:30","pubTimestamp":1755779404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nFWN3UD04W:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","LU1066053197.SGD","LU0889565916.HKD","GILD","SG9999015978.USD","LU0320765992.SGD","LU1778281490.HKD","IE00B3T34201.USD","LU1066051498.USD","IE0002270589.USD","BK4585","LU1571399168.USD","LU2324357040.USD","BK4532","LU1674673691.USD","LU0058720904.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","BK4588","BK4568","IE00B19Z3581.USD","LU0289739699.SGD","BK4139","LU1674673428.USD","BK4550","IE00BKVL7J92.USD","LU1430594728.SGD","LU1585245621.USD","SG9999015945.SGD","LU0109394709.USD","LU2089984988.USD","BK4566","BK4578","IE00B19Z3B42.SGD","LU0823416689.USD","LU1839511570.USD","SG9999015952.SGD","LU2468319806.SGD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","SG9999015986.USD","LU2087621335.USD"],"gpt_icon":0},{"id":"2561460643","title":"Kite to Acquire Interius Biotherapeutics to Advance in Vivo Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2561460643","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561460643?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:30","pubTimestamp":1755779404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nFWN3UD04W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BKVL7J92.USD","LU0109394709.USD","IE00B19Z3581.USD","LU1571399168.USD","LU2324357040.USD","LU1430594728.SGD","LU0320765992.SGD","BK4578","LU0889565916.HKD","LU2089984988.USD","BK4566","LU0823416689.USD","IE00B19Z3B42.SGD","LU1066051498.USD","LU2468319806.SGD","IE00B7SZLL34.SGD","GILD","LU0234570918.USD","LU1674673691.USD","LU0289739699.SGD","LU1066053197.SGD","LU0058720904.USD","BK4532","BK4588","LU1778281490.HKD","SG9999015945.SGD","SG9999015978.USD","BK4550","LU2087621335.USD","IE00BSNM7G36.USD","LU1839511570.USD","BK4583","LU1585245621.USD","BK4568","BK4139","IE00BZ1G4Q59.USD","LU1674673428.USD","SG9999015952.SGD","IE00B3T34201.USD","IE0002270589.USD","BK4585","SG9999015986.USD"],"gpt_icon":0},{"id":"2561460624","title":"Kite: Proposed Deal for $350 Mln.","url":"https://stock-news.laohu8.com/highlight/detail?id=2561460624","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561460624?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:30","pubTimestamp":1755779404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nFWN3UD04W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1585245621.USD","LU2468319806.SGD","IE0002270589.USD","LU0889565916.HKD","IE00B19Z3B42.SGD","IE00B3T34201.USD","BK4583","IE00B7SZLL34.SGD","LU0289739699.SGD","IE00BSNM7G36.USD","LU1066051498.USD","LU1066053197.SGD","LU1674673428.USD","LU2089984988.USD","IE00B19Z3581.USD","BK4568","LU2324357040.USD","GILD","BK4588","BK4139","IE00BKVL7J92.USD","SG9999015945.SGD","SG9999015986.USD","LU0234570918.USD","LU0823416689.USD","LU2087621335.USD","BK4578","SG9999015952.SGD","BK4532","LU1839511570.USD","LU1674673691.USD","LU1778281490.HKD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU0058720904.USD","BK4585","LU0109394709.USD","BK4566","BK4550","LU1571399168.USD","SG9999015978.USD","LU1430594728.SGD"],"gpt_icon":0},{"id":"2561462881","title":"Shares of Gilead Down 2.9% Premarket After Reuters Report CVS Holds off Adding Co's New Hiv Prevention Shot to Drug Coverage Lists","url":"https://stock-news.laohu8.com/highlight/detail?id=2561462881","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561462881?lang=en_us&edition=fundamental","pubTime":"2025-08-21 19:40","pubTimestamp":1755776425,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nL4N3UD0PI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B19Z3581.USD","IE00B7SZLL34.SGD","LU2089984988.USD","IE00B19Z3B42.SGD","BK4588","SG9999015945.SGD","GILD","BK4139","SG9999015978.USD","BK4532","LU1066051498.USD","IE00BSNM7G36.USD","LU1430594728.SGD","LU1571399168.USD","LU1674673428.USD","BK4566","BK4568","BK4583","LU1778281490.HKD","IE00BKVL7J92.USD","IE00B3T34201.USD","LU2468319806.SGD","SG9999015952.SGD","LU0289739699.SGD","IE0002270589.USD","LU0109394709.USD","BK4578","LU2087621335.USD","LU1674673691.USD","LU0889565916.HKD","IE00BZ1G4Q59.USD","LU1066053197.SGD","LU2324357040.USD","LU0058720904.USD","BK4550","LU0234570918.USD","LU1839511570.USD","BK4585","SG9999015986.USD","LU0823416689.USD","LU1585245621.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2561892974","title":"Gilead Sciences Inc. to Present at Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2561892974","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561892974?lang=en_us&edition=fundamental","pubTime":"2025-08-21 04:06","pubTimestamp":1755720391,"startTime":"0","endTime":"0","summary":"Gilead Sciences Inc. announced that its executives will be speaking at the Cantor Global Healthcare Conference on Wednesday, September 3. The live webcast of the presentation will be available on the company's investors page.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via Business Wire  on August 20, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL7W82Pr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4566","LU1778281490.HKD","LU1585245621.USD","LU2087621335.USD","LU1571399168.USD","LU0289739699.SGD","LU0889565916.HKD","LU1066051498.USD","GILD","LU1839511570.USD","BK4550","IE00B3T34201.USD","LU2324357040.USD","BK4578","IE00BZ1G4Q59.USD","LU1066053197.SGD","SG9999015952.SGD","LU0109394709.USD","SG9999015978.USD","IE00B7SZLL34.SGD","BK4139","LU1674673428.USD","IE00B19Z3B42.SGD","LU0234570918.USD","LU0320765992.SGD","BK4532","LU2089984988.USD","LU0058720904.USD","LU1430594728.SGD","IE0002270589.USD","LU2468319806.SGD","IE00BKVL7J92.USD","SG9999015986.USD","BK4585","LU1674673691.USD","BK4588","LU0823416689.USD","IE00B19Z3581.USD","BK4568","IE00BSNM7G36.USD","SG9999015945.SGD"],"gpt_icon":0},{"id":"2560177945","title":"Gilead price target raised to $135 from $120 at Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2560177945","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560177945?lang=en_us&edition=fundamental","pubTime":"2025-08-20 18:51","pubTimestamp":1755687063,"startTime":"0","endTime":"0","summary":"Bernstein raised the firm’s price target on Gilead (GILD) to $135 from $120 and keeps an Outperform rating on the shares. Gilead reported Q2 revenu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-price-target-raised-to-135-from-120-at-bernstein-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-price-target-raised-to-135-from-120-at-bernstein-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1066051498.USD","LU0058720904.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","BK4585","BK4568","LU2087621335.USD","LU0823416689.USD","LU0889565916.HKD","IE0002270589.USD","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","IE00B3T34201.USD","LU1674673691.USD","BK4550","IE00B19Z3B42.SGD","LU1778281490.HKD","LU2468319806.SGD","SG9999015978.USD","IE00B19Z3581.USD","LU0289739699.SGD","LU1571399168.USD","BK4583","GILD","LU1066053197.SGD","BK4578","BK4588","LU1674673428.USD","SG9999015945.SGD","BK4566","LU1585245621.USD","BK4139","LU1430594728.SGD","LU1839511570.USD","LU0109394709.USD","LU2324357040.USD","SG9999015952.SGD","LU0320765992.SGD","BK4532","SG9999015986.USD","LU2089984988.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2560819262","title":"Walgreens Specialty Pharmacy Expands Limited Distribution Network","url":"https://stock-news.laohu8.com/highlight/detail?id=2560819262","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560819262?lang=en_us&edition=fundamental","pubTime":"2025-08-19 21:39","pubTimestamp":1755610780,"startTime":"0","endTime":"0","summary":"Walgreens Specialty Pharmacy (WBA) said Tuesday it has expanded its limited distribution drug network to now include 265 products.The company said medications provided under limited distribution drug ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4566","BK4588","IE00B7SZLL34.SGD","BK4568","WBA","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU1066053197.SGD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","LU0234570918.USD","LU0321505439.SGD","LU1430594728.SGD","LU0109394709.USD","BK4583","WBA.AU","LU0320765992.SGD","LU1839511570.USD","LU2089984988.USD","BK4550","LU0823416689.USD","LU0289739699.SGD","SG9999015978.USD","LU1674673691.USD","LU0321505868.SGD","SG9999015945.SGD","LU2324357040.USD","BK4139","BK4578","LU2087621335.USD","IE00B3T34201.USD","IE0002270589.USD","LU2468319806.SGD","BK4532","LU1571399168.USD","BK4128","SG9999015986.USD","LU1674673428.USD","LU1066051498.USD","GILD","LU0058720904.USD","LU0889565916.HKD","LU1585245621.USD","BK4585","LU1778281490.HKD","SG9999015952.SGD"],"gpt_icon":0},{"id":"2560538641","title":"Gilead upgraded to Outperform from Neutral at Daiwa","url":"https://stock-news.laohu8.com/highlight/detail?id=2560538641","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560538641?lang=en_us&edition=fundamental","pubTime":"2025-08-19 09:40","pubTimestamp":1755567612,"startTime":"0","endTime":"0","summary":"Daiwa upgraded Gilead (GILD) to Outperform from Neutral with a $128 price target Published first on TheFly – the ultimate source for real-time, mar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-upgraded-to-outperform-from-neutral-at-daiwa-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-upgraded-to-outperform-from-neutral-at-daiwa-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BZ1G4Q59.USD","LU1066053197.SGD","IE00B19Z3581.USD","BK4568","GILD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","SG9999015945.SGD","LU0823416689.USD","LU1839511570.USD","LU0289739699.SGD","LU0320765992.SGD","LU1585245621.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","BK4532","BK4585","LU0058720904.USD","SG9999015952.SGD","LU2468319806.SGD","LU1430594728.SGD","LU2087621335.USD","LU0234570918.USD","LU1674673691.USD","LU2324357040.USD","IE00B3T34201.USD","BK4583","BK4588","IE0002270589.USD","BK4139","LU1674673428.USD","LU2089984988.USD","LU0889565916.HKD","SG9999015978.USD","BK4550","BK4578","LU1571399168.USD","LU0109394709.USD","LU1778281490.HKD","LU1066051498.USD","SG9999015986.USD","BK4566"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}]}}